Katalin Frisch
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Estrogen and related hormone effects, Bioactive Compounds and Antitumor Agents, Inflammatory mediators and NSAID effects, HER2/EGFR in Cancer Research, Phytoestrogen effects and research
Most-Cited Works
- → Estrogen Receptor Ligands. II. Discovery of Benzoxathiins as Potent, Selective Estrogen Receptor α Modulators(2004)99 cited
- → Estrogen receptor ligands. Part 1: The discovery of flavanoids with subtype selectivity(2004)52 cited
- → The discovery of tetrahydrofluorenones as a new class of estrogen receptor β-subtype selective ligands(2006)43 cited
- → 2-Phenylspiroindenes: a novel class of selective estrogen receptor modulators (SERMs)(2003)36 cited
- → Estrogen receptor β-subtype selective tetrahydrofluorenones: Use of a fused pyrazole as a phenol bioisostere(2006)34 cited
- → Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists(2006)21 cited
- → Erratum to “Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists” [Bioorg. Med. Chem. Lett. 16 (2006) 4652–4656](2006)1 cited
- → 2‐Phenylspiroindenes: A Novel Class of Selective Estrogen Receptor Modulators (SERMs).(2003)